Comparative Analysis of The Effects of Short-Term Metformin and Metformin- Insulin Combination on the Liver in Diabetes Wistar Rats

Authors

  • Sahar Mubeen
  • Rabia Rehan
  • Sundus Sadia
  • Iffat Raza
  • Sarwat Jabeen

DOI:

https://doi.org/10.51985/JBUMDC2019072

Abstract

Objective: To compare the effects of drugs (Metformin and combination) on weight, size and volume of liver in diabetic
rats.
Study Design and Setting: This was an experimental comparative study conducted at Institute of Bio Medical Sciences
(IBMS), Dow University of Health Sciences (DUHS), Ojha Campus, Karachi.
Methodology: The study was conducted on 40 albino wistar rats. Diabetic rats (n=20) were grouped into 2. One group
was treated with metformin (n=10)while the other group with insulin-metformin combination (n=10) for 4 weeks. All the
treated groups were compared with untreated diabetic killed (n=10). After a short period of 4 weeks, all the rats were
sacrificed. Livers were isolated, weighed and grossly observed for significant changes. Absolute and mean percent liver
weights as well as liver volumeof all rats were calculated.
Results: Data was analyzed by using GraphPad Prism version 5.0.Data for absolute/percent liver weight and liver volume
was expressed as Mean ± SEM. The value obtained was analyzed by Two-way ANOVA followed by Bonferroni test
wherever applicable.P-value of = 0.05 was considered as statistically significant.
Conclusion: The short-term metformin and insulin-metformin treatment doesn’t effect liver weight and volume significantly
and hence, their short-term use is beneficial in type 2 diabetes.

References

Diabetes. Percentage of diabetics in the global adult population in 2017 and 2045 2019. Available from: https://www.statista. com/statistics/271464/percentage-of-diabetics-worldwide/.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care. 2004;27(5):1047-53.

Association AD. Diagnosis and classification of diabetes mellitus. Diabetes care. 2014;37(Supplement 1):S81-S90.

Srinivasan K, Viswanad B, Asrat L, Kaul C, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin- treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological research. 2005;52(4):313-20.

Borghi C, Ventura F. Decrease mortality in type II diabetes mellitus: glycemic and renal function control. Journal of Cardiovascular Medicine. 2018;19:e13-e5.

Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014;59(2):713-23.

Lingvay I, Raskin P, Szczepaniak LS. Effect of insulin–metformin combination on hepatic steatosis in patients with type 2 diabetes. Journal of diabetes and its complications. 2007;21(3):137-42.

Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48(4):634-42.

Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML, Vecchione R, et al. Silent non-alcoholic fatty liver disease—a clinical–histological study. Journal of hepatology. 2004;41(5):751-7.

Bedossa P. Pathology of non-alcoholic fatty liver disease. Liver International. 2017;37:85-9.

Giorda C, Forlani G, Manti R, Mazzella N, De Cosmo S, Rossi MC, et al. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes/metabolism research and reviews. 2017;33(4):e2878.

Silvares RR, Pereira ENGdS, Flores EEI, Estato V, Reis PA, Silva IJd, et al. Combined therapy with metformin and insulin attenuates systemic and hepatic alterations in a model of high- fat diet-/streptozotocin-induced diabetes. International journal of experimental pathology. 2016;97(3):266-77.

Abeeleh MA, Ismail ZB, Alzaben KR, Abu-Halaweh SA, Al- Essa MK, Abuabeeleh J, et al. Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: a comparison between 2 strains of rats. Eur J Sci Res. 2009;32(3):398-402.

Mubeen S, Amjad Z, Memon FM, Ashraf SU. The Short-term Effects of Insulin, Metformin and Insulin-Metformin Combination on the Liver Morphology in High Fat Diet/Streptozotocin Induced Diabetic Albino Rats. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP. 2016;26(12):962-6.

Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez- Cuervo C, Berger Z, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Annals of internal medicine. 2016;164(11):740-51.

Eriksson A, Attvall S, Bonnier M, Eriksson JW, Rosander B, Karlsson FA. Short-term effects of metformin in type 2 diabetes. Diabetes, obesity and metabolism. 2007;9(3):330- 6.

Dmitri K, McFarlane Samy I, Sowers James R. Metformin: an update. Ann Intern Med. 2002;137(1):25-33.

Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000;49(12):2063-9.

Hattori Y, Suzuki K, Hattori S, Kasai K. Metformin inhibits cytokine-induced nuclear factor êB activation via AMP- activated protein kinase activation in vascular endothelial cells. Hypertension. 2006;47(6):1183-8.

Forcheron F, Abdallah P, Basset A, Del Carmine P, Haffar G, Beylot M. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. Obesity. 2009;17(7):1381-9.

Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008;48(1):119-28.

Sagi R, Reif S, Neuman G, Webb M, Phillip M, Shalitin S. Nonalcoholic fatty liver disease in overweight children and adolescents. Acta Paediatrica. 2007;96(8):1209-13.

Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I. Metformin protects against the development of fructose- induced steatosis in mice: role of the intestinal barrier function. Laboratory investigation. 2012;92(7):1020.

Downloads

Published

2021-03-17

How to Cite

Sahar Mubeen, Rabia Rehan, Sundus Sadia, Raza, I. ., & Jabeen, S. . (2021). Comparative Analysis of The Effects of Short-Term Metformin and Metformin- Insulin Combination on the Liver in Diabetes Wistar Rats. Journal of Bahria University Medical and Dental College, 10(1), 26–29. https://doi.org/10.51985/JBUMDC2019072

Issue

Vol. 10 No. 1 (2020): Volume 10 Issue 1

Section

Original Articles

License

Copyright (c) 2020 Sahar Mubeen; Rabia Rehan, Sundus Sadia; Iffat Raza, Sarwat Jabeen

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0